Mark E. Saad - 27 Feb 2024 Form 4 Insider Report for Axsome Therapeutics, Inc. (AXSM)

Role
Director
Signature
/s/ Herriot Tabuteau, M.D., Attorney in Fact
Issuer symbol
AXSM
Transactions as of
27 Feb 2024
Net transactions value
$0
Form type
4
Filing time
29 Feb 2024, 18:34:13 UTC
Previous filing
06 Jun 2023
Next filing
11 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXSM Stock Option (Right to Buy) Award $0 +1,519 $0.000000 1,519 27 Feb 2024 Common Stock 1,519 $84.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 1,519 options elected to be received in lieu of cash compensation earned in 2023. All of such options are immediately exercisable.